Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 135 entries
Sorted by: Best Match Show Resources per page
Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo.

Annals of burns and fire disasters

Buja Z, Arifi H, Hoxha E, Duqi S.
PMID: 27279808
Ann Burns Fire Disasters. 2015 Sep 30;28(3):205-9.

Burn injuries are very frequent in Kosovo, leading to long-lasting physical, functional, aesthetic, psychological and social consequences directly proportional to the time of healing; the longer it takes for the burn wound to heal, the more serious are the...

Cite
Buja Z, Arifi H, Hoxha E, et al. Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo. Ann Burns Fire Disasters. 2015;28(3):205-9
Buja, Z., Arifi, H., Hoxha, E., & Duqi, S. (2015). Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo. Annals of burns and fire disasters, 28(3), 205-9.
Buja, Z, et al. "Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo." Annals of burns and fire disasters vol. 28,3 (2015): 205-9.
Buja Z, Arifi H, Hoxha E, Duqi S. Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo. Ann Burns Fire Disasters. 2015 Sep 30;28(3):205-9. PMID: 27279808; PMCID: PMC4883606.
Copy Download .nbib Format: NLM
Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months.

Open access Macedonian journal of medical sciences

Qorraj-Bytyqi H, Hoxha R, Sadiku S, Bajraktari IH, Sopjani M, Thaçi K, Thaçi S, Bahtiri E.
PMID: 29610598
Open Access Maced J Med Sci. 2018 Mar 12;6(3):442-446. doi: 10.3889/oamjms.2018.142. eCollection 2018 Mar 15.

BACKGROUND: Proton pump inhibitors (PPIs) represent the most widely prescribed antisecretory agents, but their prolonged use, may influence iron and vitamin B12 status, which could have important implications for clinical practice.AIM: We undertook this study aiming to investigate the...

Cite
Qorraj-Bytyqi H, Hoxha R, Sadiku S, et al. Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months. Open Access Maced J Med Sci. 2018;6(3):442-446doi: 10.3889/oamjms.2018.142.
Qorraj-Bytyqi, H., Hoxha, R., Sadiku, S., Bajraktari, I. H., Sopjani, M., Thaçi, K., Thaçi, S., & Bahtiri, E. (2018). Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months. Open access Macedonian journal of medical sciences, 6(3), 442-446. https://doi.org/10.3889/oamjms.2018.142
Qorraj-Bytyqi, Hasime, et al. "Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months." Open access Macedonian journal of medical sciences vol. 6,3 (2018): 442-446. doi: https://doi.org/10.3889/oamjms.2018.142
Qorraj-Bytyqi H, Hoxha R, Sadiku S, Bajraktari IH, Sopjani M, Thaçi K, Thaçi S, Bahtiri E. Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months. Open Access Maced J Med Sci. 2018 Mar 12;6(3):442-446. doi: 10.3889/oamjms.2018.142. eCollection 2018 Mar 15. PMID: 29610598; PMCID: PMC5874363.
Copy Download .nbib Format: NLM
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Frontiers in cardiovascular medicine

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.
PMID: 30873413
Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

No abstract available.

Cite
Fredi M, Andreoli L, Bacco B, et al. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Front Cardiovasc Med. 2019;6:11doi: 10.3389/fcvm.2019.00011.
Fredi, M., Andreoli, L., Bacco, B., Bertero, T., Bortoluzzi, A., Breda, S., Cappa, V., Ceccarelli, F., Cimaz, R., De Vita, S., Di Poi, E., Elefante, E., Franceschini, F., Gerosa, M., Govoni, M., Hoxha, A., Lojacono, A., Marozio, L., Mathieu, A., Meroni, P. L., Minniti, A., Mosca, M., Muscarà, M., Padovan, M., Piga, M., Priori, R., Ramoni, V., Ruffatti, A., Tani, C., Tonello, M., Trespidi, L., Zatti, S., Calza, S., Tincani, A., & Brucato, A. (2019). First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Frontiers in cardiovascular medicine, 611. https://doi.org/10.3389/fcvm.2019.00011
Fredi, Micaela, et al. "First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)." Frontiers in cardiovascular medicine vol. 6 (2019): 11. doi: https://doi.org/10.3389/fcvm.2019.00011
Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019. PMID: 30873413; PMCID: PMC6404544.
Copy Download .nbib Format: NLM
Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action.

Frontiers in pharmacology

Robertson J, Iwamoto K, Hoxha I, Ghazaryan L, Abilova V, Cvijanovic A, Pyshnik H, Darakhvelidze M, Makalkina L, Jakupi A, Dzhakubekova A, Carp A, Cizmovic L, Rachina S, Radonjic V, Yusufi S, Aksoy M, Ibragimova M, Godman B, Kluge H, Pedersen HB.
PMID: 30890943
Front Pharmacol. 2019 Mar 05;9:1156. doi: 10.3389/fphar.2018.01156. eCollection 2018.

No abstract available.

Cite
Robertson J, Iwamoto K, Hoxha I, et al. Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action. Front Pharmacol. 2019;9:1156doi: 10.3389/fphar.2018.01156.
Robertson, J., Iwamoto, K., Hoxha, I., Ghazaryan, L., Abilova, V., Cvijanovic, A., Pyshnik, H., Darakhvelidze, M., Makalkina, L., Jakupi, A., Dzhakubekova, A., Carp, A., Cizmovic, L., Rachina, S., Radonjic, V., Yusufi, S., Aksoy, M., Ibragimova, M., Godman, B., Kluge, H., & Pedersen, H. B. (2018). Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action. Frontiers in pharmacology, 91156. https://doi.org/10.3389/fphar.2018.01156
Robertson, Jane, et al. "Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action." Frontiers in pharmacology vol. 9 (2018): 1156. doi: https://doi.org/10.3389/fphar.2018.01156
Robertson J, Iwamoto K, Hoxha I, Ghazaryan L, Abilova V, Cvijanovic A, Pyshnik H, Darakhvelidze M, Makalkina L, Jakupi A, Dzhakubekova A, Carp A, Cizmovic L, Rachina S, Radonjic V, Yusufi S, Aksoy M, Ibragimova M, Godman B, Kluge H, Pedersen HB. Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action. Front Pharmacol. 2019 Mar 05;9:1156. doi: 10.3389/fphar.2018.01156. eCollection 2018. PMID: 30890943; PMCID: PMC6411709.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in neuroanatomy

Zhang Y, Hoxha E, Zhao T, Zhou X, Alvarez-Bolado G.
PMID: 28725186
Front Neuroanat. 2017 Jul 05;11:53. doi: 10.3389/fnana.2017.00053. eCollection 2017.

Oligodendrocyte precursor cells (OPC), neurons and astrocytes share a neural progenitor cell (NPC) in the early ventricular zone (VZ) of the embryonic neuroepithelium. Both switch to produce either of the three cell types and the generation of the right...

Cite
Zhang Y, Hoxha E, Zhao T, et al. . Front Neuroanat. 2017;11:53doi: 10.3389/fnana.2017.00053.
Zhang, Y., Hoxha, E., Zhao, T., Zhou, X., & Alvarez-Bolado, G. (2017). . Frontiers in neuroanatomy, 1153. https://doi.org/10.3389/fnana.2017.00053
Zhang, Yuanfeng, et al. "." Frontiers in neuroanatomy vol. 11 (2017): 53. doi: https://doi.org/10.3389/fnana.2017.00053
Zhang Y, Hoxha E, Zhao T, Zhou X, Alvarez-Bolado G. . Front Neuroanat. 2017 Jul 05;11:53. doi: 10.3389/fnana.2017.00053. eCollection 2017. PMID: 28725186; PMCID: PMC5496944.
Copy Download .nbib Format: NLM
Public Health Profile of Road Traffic Accidents in Kosovo 2010-2015.

Open access Macedonian journal of medical sciences

Ramadani N, Zhjeqi V, Berisha M, Hoxha R, Begolli I, Salihu D, Krasniqi P.
PMID: 29362641
Open Access Maced J Med Sci. 2017 Dec 13;5(7):1036-1041. doi: 10.3889/oamjms.2017.214. eCollection 2017 Dec 15.

AIM: To determine the characteristics of the Socio-medical profile of road traffic accidents in Kosovo, between 2010 and 2015 year.STUDY DESIGN: Retrospective study.METHODS: A descriptive method based on the database of road traffic accidents from the National Police of...

Cite
Ramadani N, Zhjeqi V, Berisha M, et al. Public Health Profile of Road Traffic Accidents in Kosovo 2010-2015. Open Access Maced J Med Sci. 2017;5(7):1036-1041doi: 10.3889/oamjms.2017.214.
Ramadani, N., Zhjeqi, V., Berisha, M., Hoxha, R., Begolli, I., Salihu, D., & Krasniqi, P. (2017). Public Health Profile of Road Traffic Accidents in Kosovo 2010-2015. Open access Macedonian journal of medical sciences, 5(7), 1036-1041. https://doi.org/10.3889/oamjms.2017.214
Ramadani, Naser, et al. "Public Health Profile of Road Traffic Accidents in Kosovo 2010-2015." Open access Macedonian journal of medical sciences vol. 5,7 (2017): 1036-1041. doi: https://doi.org/10.3889/oamjms.2017.214
Ramadani N, Zhjeqi V, Berisha M, Hoxha R, Begolli I, Salihu D, Krasniqi P. Public Health Profile of Road Traffic Accidents in Kosovo 2010-2015. Open Access Maced J Med Sci. 2017 Dec 13;5(7):1036-1041. doi: 10.3889/oamjms.2017.214. eCollection 2017 Dec 15. PMID: 29362641; PMCID: PMC5771275.
Copy Download .nbib Format: NLM
Elovl5 is required for proper action potential conduction along peripheral myelinated fibers.

Glia

Hoxha E, Balbo I, Parolisi R, Audano M, Montarolo F, Ravera F, Guglielmotto M, Muratori L, Raimondo S, DiGregorio E, Buffo A, Brusco A, Borroni B, Mitro N, Caruso D, Tempia F.
PMID: 34139039
Glia. 2021 Oct;69(10):2419-2428. doi: 10.1002/glia.24048. Epub 2021 Jun 17.

Elovl5 elongates fatty acids with 18 carbon atoms and in cooperation with other enzymes guarantees the normal levels of very long-chain fatty acids, which are necessary for a proper membrane structure. Action potential conduction along myelinated axons depends on...

Cite
Hoxha E, Balbo I, Parolisi R, et al. Elovl5 is required for proper action potential conduction along peripheral myelinated fibers. Glia. 2021;69(10):2419-2428doi: 10.1002/glia.24048.
Hoxha, E., Balbo, I., Parolisi, R., Audano, M., Montarolo, F., Ravera, F., Guglielmotto, M., Muratori, L., Raimondo, S., DiGregorio, E., Buffo, A., Brusco, A., Borroni, B., Mitro, N., Caruso, D., & Tempia, F. (2021). Elovl5 is required for proper action potential conduction along peripheral myelinated fibers. Glia, 69(10), 2419-2428. https://doi.org/10.1002/glia.24048
Hoxha, Eriola, et al. "Elovl5 is required for proper action potential conduction along peripheral myelinated fibers." Glia vol. 69,10 (2021): 2419-2428. doi: https://doi.org/10.1002/glia.24048
Hoxha E, Balbo I, Parolisi R, Audano M, Montarolo F, Ravera F, Guglielmotto M, Muratori L, Raimondo S, DiGregorio E, Buffo A, Brusco A, Borroni B, Mitro N, Caruso D, Tempia F. Elovl5 is required for proper action potential conduction along peripheral myelinated fibers. Glia. 2021 Oct;69(10):2419-2428. doi: 10.1002/glia.24048. Epub 2021 Jun 17. PMID: 34139039; PMCID: PMC8453547.
Copy Download .nbib Format: NLM
New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick.

Trends in cancer

Kesavan R, Rion H, Hoxhaj G.
PMID: 33500224
Trends Cancer. 2021 Mar;7(3):177-179. doi: 10.1016/j.trecan.2021.01.003. Epub 2021 Jan 23.

The molecular elements that govern cellular transformation and tumorigenic competence remain poorly understood. Metabolic reprogramming has emerged as a hallmark of malignant transformation. Recently in Cell Metabolism, Zhang et al. showed that an increase of cellular antioxidant capacity and...

Cite
Kesavan R, Rion H, Hoxhaj G. New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick. Trends Cancer. 2021;7(3):177-179doi: 10.1016/j.trecan.2021.01.003.
Kesavan, R., Rion, H., & Hoxhaj, G. (2021). New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick. Trends in cancer, 7(3), 177-179. https://doi.org/10.1016/j.trecan.2021.01.003
Kesavan, Rushendhiran, et al. "New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick." Trends in cancer vol. 7,3 (2021): 177-179. doi: https://doi.org/10.1016/j.trecan.2021.01.003
Kesavan R, Rion H, Hoxhaj G. New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick. Trends Cancer. 2021 Mar;7(3):177-179. doi: 10.1016/j.trecan.2021.01.003. Epub 2021 Jan 23. PMID: 33500224.
Copy Download .nbib Format: NLM
Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health.

Journal of personalized medicine

Traversi D, Pulliero A, Izzotti A, Franchitti E, Iacoviello L, Gianfagna F, Gialluisi A, Izzi B, Agodi A, Barchitta M, Calabrò GE, Hoxhaj I, Sassano M, Sbrogiò LG, Del Sole A, Marchiori F, Pitini E, Migliara G, Marzuillo C, De Vito C, Tamburro M, Sammarco ML, Ripabelli G, Villari P, Boccia S.
PMID: 33669364
J Pers Med. 2021 Feb 16;11(2). doi: 10.3390/jpm11020135.

The development of high-throughput omics technologies represents an unmissable opportunity for evidence-based prevention of adverse effects on human health. However, the applicability and access to multi-omics tests are limited. In Italy, this is due to the rapid increase of...

Cite
Traversi D, Pulliero A, Izzotti A, et al. Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health. J Pers Med. 2021;11(2)doi: 10.3390/jpm11020135.
Traversi, D., Pulliero, A., Izzotti, A., Franchitti, E., Iacoviello, L., Gianfagna, F., Gialluisi, A., Izzi, B., Agodi, A., Barchitta, M., Calabrò, G. E., Hoxhaj, I., Sassano, M., Sbrogiò, L. G., Del Sole, A., Marchiori, F., Pitini, E., Migliara, G., Marzuillo, C., De Vito, C., Tamburro, M., Sammarco, M. L., Ripabelli, G., Villari, P., & Boccia, S. (2021). Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health. Journal of personalized medicine, 11(2), . https://doi.org/10.3390/jpm11020135
Traversi, Deborah, et al. "Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health." Journal of personalized medicine vol. 11,2 (2021). doi: https://doi.org/10.3390/jpm11020135
Traversi D, Pulliero A, Izzotti A, Franchitti E, Iacoviello L, Gianfagna F, Gialluisi A, Izzi B, Agodi A, Barchitta M, Calabrò GE, Hoxhaj I, Sassano M, Sbrogiò LG, Del Sole A, Marchiori F, Pitini E, Migliara G, Marzuillo C, De Vito C, Tamburro M, Sammarco ML, Ripabelli G, Villari P, Boccia S. Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health. J Pers Med. 2021 Feb 16;11(2). doi: 10.3390/jpm11020135. PMID: 33669364; PMCID: PMC7920275.
Copy Download .nbib Format: NLM
An Automated Workflow for the Electric Field Modeling of High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke with Lesions.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Handiru VS, Mark D, Hoxha A, Allexandre D.
PMID: 34892636
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:6663-6666. doi: 10.1109/EMBC46164.2021.9629584.

Transcranial Direct Current Stimulation is a popular noninvasive brain stimulation (NIBS) technique that modulates brain excitability by means of low-amplitude electrical current (usually

Cite
Handiru VS, Mark D, Hoxha A, et al. An Automated Workflow for the Electric Field Modeling of High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke with Lesions. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:6663-6666doi: 10.1109/EMBC46164.2021.9629584.
Handiru, V. S., Mark, D., Hoxha, A., & Allexandre, D. (2021). An Automated Workflow for the Electric Field Modeling of High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke with Lesions. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20216663-6666. https://doi.org/10.1109/EMBC46164.2021.9629584
Handiru, Vikram Shenoy, et al. "An Automated Workflow for the Electric Field Modeling of High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke with Lesions." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 6663-6666. doi: https://doi.org/10.1109/EMBC46164.2021.9629584
Handiru VS, Mark D, Hoxha A, Allexandre D. An Automated Workflow for the Electric Field Modeling of High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke with Lesions. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:6663-6666. doi: 10.1109/EMBC46164.2021.9629584. PMID: 34892636.
Copy Download .nbib Format: NLM
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina.

International journal of environmental research and public health

Gashi B, Osmani V, Halili R, Hoxha T, Kamberi A, Hoti N, Agahi R, Basha V, Berisha V, Hoxha I.
PMID: 34886272
Int J Environ Res Public Health. 2021 Nov 28;18(23). doi: 10.3390/ijerph182312545.

BACKGROUND: Some studies have assessed the seroprevalence of anti-SARS-CoV-2 antibodies in different populations. Very few studies have explored seroprevalence in municipal workers, an important and potentially high-risk population. This study aims to determine the prevalence of anti-SARS-CoV-2 antibodies in...

Cite
Gashi B, Osmani V, Halili R, et al. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina. Int J Environ Res Public Health. 2021;18(23)doi: 10.3390/ijerph182312545.
Gashi, B., Osmani, V., Halili, R., Hoxha, T., Kamberi, A., Hoti, N., Agahi, R., Basha, V., Berisha, V., & Hoxha, I. (2021). Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina. International journal of environmental research and public health, 18(23), . https://doi.org/10.3390/ijerph182312545
Gashi, Bujar, et al. "Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina." International journal of environmental research and public health vol. 18,23 (2021). doi: https://doi.org/10.3390/ijerph182312545
Gashi B, Osmani V, Halili R, Hoxha T, Kamberi A, Hoti N, Agahi R, Basha V, Berisha V, Hoxha I. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina. Int J Environ Res Public Health. 2021 Nov 28;18(23). doi: 10.3390/ijerph182312545. PMID: 34886272.
Copy Download .nbib Format: NLM
Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome.

Blood

Ruffatti A, Tonello M, Macor P, Calligaro A, Del Ross T, Favaro M, Lotti V, Carletto A, Hoxha A, Biasi D.
PMID: 33649771
Blood. 2021 May 27;137(21):2989-2992. doi: 10.1182/blood.2020010575.

No abstract available.

Cite
Ruffatti A, Tonello M, Macor P, et al. Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood. 2021;137(21):2989-2992doi: 10.1182/blood.2020010575.
Ruffatti, A., Tonello, M., Macor, P., Calligaro, A., Del Ross, T., Favaro, M., Lotti, V., Carletto, A., Hoxha, A., & Biasi, D. (2021). Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood, 137(21), 2989-2992. https://doi.org/10.1182/blood.2020010575
Ruffatti, Amelia, et al. "Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome." Blood vol. 137,21 (2021): 2989-2992. doi: https://doi.org/10.1182/blood.2020010575
Ruffatti A, Tonello M, Macor P, Calligaro A, Del Ross T, Favaro M, Lotti V, Carletto A, Hoxha A, Biasi D. Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood. 2021 May 27;137(21):2989-2992. doi: 10.1182/blood.2020010575. PMID: 33649771.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 135 entries